The scientist’s investigation covers issues in Genetics, Gene, Germline mutation, Adenocarcinoma and Mutation. Her research related to Genome, Human genome, Exome, Mutation rate and Somatic cell might be considered part of Genetics. As a part of the same scientific study, Carrie Sougnez usually deals with the Genome, concentrating on Exome sequencing and frequently concerns with Genomics and Cancer.
When carried out as part of a general Gene research project, her work on Tumor suppressor gene is frequently linked to work in Oncogene, therefore connecting diverse disciplines of study. Her Germline mutation study integrates concerns from other disciplines, such as Molecular biology, Adenocarcinoma of the lung and MET Exon 14 Skipping Mutation. Her Mutation study incorporates themes from Mesenchymal Glioblastoma, Phenotype, Telomerase and DNA methylation.
Carrie Sougnez spends much of her time researching Genetics, Exome sequencing, Cancer research, Mutation and Germline mutation. Her Genetics study is mostly concerned with Exome, Cancer, Gene, Genome and Point mutation. Her Gene research is multidisciplinary, incorporating perspectives in Computational biology and Adenocarcinoma.
Carrie Sougnez interconnects Bioinformatics, Somatic cell, KRAS, Neuroblastoma RAS viral oncogene homolog and PTEN in the investigation of issues within Cancer research. The Mutation study combines topics in areas such as Molecular biology, Chronic lymphocytic leukemia, Loss of heterozygosity and Somatic evolution in cancer. In her research on the topic of Germline mutation, Histone methylation is strongly related with Cancer genome sequencing.
Her primary areas of study are Genetics, Cancer research, Mutation, Exome sequencing and Somatic evolution in cancer. Her study in Genetics concentrates on DNA sequencing, [email protected], Human genome, Gene and Bisulfite sequencing. She combines subjects such as Bioinformatics, Somatic cell, Point mutation, Monoubiquitination and Adenocarcinoma with her study of Cancer research.
The study incorporates disciplines such as Genetic heterogeneity and Exome in addition to Bioinformatics. Her work in Somatic cell tackles topics such as Germline mutation which are related to areas like MLH1. Her research integrates issues of Whole genome sequencing and Massive parallel sequencing in her study of Mutation.
Her primary scientific interests are in Cancer research, Bioinformatics, Somatic cell, Genetic heterogeneity and Germline mutation. Her Cancer research research incorporates themes from CpG Island Methylator Phenotype, MLH1 and Lynch syndrome. Her Bioinformatics study frequently draws parallels with other fields, such as Exome.
Her Exome study necessitates a more in-depth grasp of Mutation. Her research in Germline mutation intersects with topics in MET Exon 14 Skipping Mutation, DNA mismatch repair and Adenocarcinoma. Her Adenocarcinoma of the lung study in the realm of Adenocarcinoma connects with subjects such as Oncogene.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina;Giordano Caponigro;Nicolas Stransky;Kavitha Venkatesan.
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan;Roel G W Verhaak;Aaron McKenna;Benito Campos.
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass;Vesteinn Thorsson;Ilya Shmulevich;Sheila M. Reynolds.
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence;Petar Stojanov;Petar Stojanov;Paz Polak;Paz Polak;Paz Polak;Gregory V. Kryukov;Gregory V. Kryukov;Gregory V. Kryukov.
Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network
Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger.
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis;Michael S Lawrence;Scott L Carter;Andrey Sivachenko.
Nature Biotechnology (2013)
Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels
Richa Saxena;Benjamin F. Voight;Valeriya Lyssenko;Noël P. Burtt.
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding;Gad Getz;David A. Wheeler;Elaine R. Mardis.
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
N. Stransky;A. M. Egloff;A. D. Tward;A. D. Kostic.
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing
Marcin Imielinski;Alice H. Berger;Alice H. Berger;Peter S. Hammerman;Peter S. Hammerman;Bryan Hernandez.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: